Skip to content
value.today

Aadi Bioscience, Inc.

AADI
$48 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Aadi Bioscience, Inc. in brief

Aadi Bioscience, Inc. is a listed company in the Biotechnology industry, based in California, USA. Its last known market value was $48 M (January 2024); there is no current figure.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Aadi Bioscience, Inc.

Aadi Bioscience, Inc. is a clinical stage biopharmaceutical company developing precision therapies for genetically defined cancers. The company annual revenue is 15 million USD and total assets are 44.9 million USD as on 2020. The headquarters is in USA.

Market cap history

$0 M$128 M$256 M$384 M$512 M20232024

World rank over time

▼ down 11,296 places since 2022
2022-01-07: #13836#13,83620222022-12-25: #15381#15,38120222023-07-30: #20208#20,20820232024-01-05: #25132#25,1322024

Rank in USA: #2,987 (Jan 2022) · #3,155 (Dec 2022) · #3,956 (Jul 2023) · #4,077 (Jan 2024)

Product recalls by Aadi Bioscience, Inc.#

1 recalls since 2015, 2,333 units in the notices that give a number. Drugs (FDA): 1.

Aadi Bioscience, Inc.: product recalls
DateWhat and whyUnitsNotice
Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.Failed Stability SpecificationsDrugsClass III2,333D-0059-2023

Source: NHTSA, CPSC and FDA recall notices. Recalls filed under a subsidiary with a different name may be missing. The number of recalls says nothing about their seriousness

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Aadi Bioscience, Inc.🇺🇸$48 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Profile updated:
Nov 4, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Aadi Bioscience, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Aadi Bioscience, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Aadi Bioscience, Inc.? Suggest a correction